IP Verse

Storage Stable Composition Comprising Rifaximin Alpha - EP3373914

The patent EP3373914 was granted to Sandoz on Jun 1, 2022. The application was originally filed on Mar 22, 2017 under application number EP17712504A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP3373914

SANDOZ
Application Number
EP17712504A
Filing Date
Mar 22, 2017
Status
Patent Maintained As Amended
Apr 29, 2022
Grant Date
Jun 1, 2022
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

ALFASIGMAJan 24, 2020HIEBLADMISSIBLE

Patent Citations (7) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONEP1557421
DESCRIPTIONEP1698630
INTERNATIONAL-SEARCH-REPORTUS2008262012
INTERNATIONAL-SEARCH-REPORTUS9018225
INTERNATIONAL-SEARCH-REPORTWO2014091432
OPPOSITIONEP1557421
OPPOSITIONWO2006094737

Non-Patent Literature (NPL) Citations (7) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- BRAGA ET AL., CRYSTENGCOMM, (2012), vol. 14, pages 6404 - 6411-
INTERNATIONAL-SEARCH-REPORT- KIBBE A H (ED) ED - KIBBE A H (ED), Handbook of Pharmaceutical Excipients, 3rd Ed, HANDBOOK OF PHARMACEUTICAL EXCIPIENTS, AMERICAN PHARMACEUTICAL ASSOC. [U.A.], WASHINGTON, DC; US, PAGE(S) 102 - 106, (20000101), ISBN 978-0-85369-381-9, XP002170947 [A] 1-12 * the whole document *-
OPPOSITION- RAYMOND C ROWE et al., Handbook of Pharmaceutical Excipients, (20060000), ISBN 0-85369-618-7, pages 132 - 135, XP055677445-
OPPOSITION- RITSCHEL WOLFGANG A. et al., Die Tablette: Handbuch der Entwicklung, (20020000), XP055616680-
OPPOSITION- "Xifaxan; Generic Name: rifaximin; Dosage Form: tablet", (20190701), pages 1 - 28, URL: Drugs.com, XP055677448-
OPPOSITION- VISCOMI G.C. et al., "Crystal forms of rifaxmin and their effect on pharmaceutical properties", CrystEngComm, (20080000), vol. 10, pages 10 74 - 1081, XP009152378
OPPOSITION- BLANDIZZI et al., Drug Design, Development and Therapy, (20150000), vol. 9, pages 1 - 11, XP055297628

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents